Account Login
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Celyad Sa ADR (NQ: CYAD )

4.395 USD +0.035 (+0.80%)
Streaming Delayed Price Updated: 3:49 PM EDT, Sep 17, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,680
Open 4.340
Bid (Size) 4.040 (3)
Ask (Size) 5.000 (5)
Prev. Close 4.360
Today's Range 4.290 - 4.410
52wk Range 3.760 - 10.31
Shares Outstanding 13,942,344
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Celyad Oncology Announces September 2021 Conferences Schedule
From GlobeNewswire News Releases
Celyad Oncology Reports First Half 2021 Financial Results and Recent Business Highlights
From GlobeNewswire News Releases

Performance

YTD
-45.94%
-45.94%
1 Month
+7.20%
+7.20%
3 Month
-20.09%
-20.09%
6 Month
-41.79%
-41.79%
1 Year
-56.44%
-56.44%

More News

Read More
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
From GlobeNewswire News Releases
Celyad Oncology to Announce First Half 2021 Financial Results and Host Conference Call
From GlobeNewswire News Releases
Celyad Oncology Presents Updates on Allogeneic CAR T Clinical Candidates and shRNA-based Preclinical Concepts at Research & Development Day
From GlobeNewswire News Releases
Celyad Oncology to Host Virtual Research & Development Webinar on July 20th
From GlobeNewswire News Releases
Celyad Oncology to Participate at the William Blair Biotech Focus Conference 2021
From GlobeNewswire News Releases
Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
From GlobeNewswire News Releases
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Tags KURA PRTK ORPH
From Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Tags ZIVO FLXN PASG
From Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Tags Earnings DMTK SYN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.